Life sciences giant Thermo Fisher Scientific has agreed to acquire clinical trials software company Clario for a consideration of up to $9.4bn.

Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development. Clinical development faces mounting pressure to deliver therapies quickly ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the ...

Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, ...

This one-day symposium on Friday, Nov. 14, will convene leaders in neuroscience, clinical research, biomedical engineering, and data science to explore strategies for advancing open and equitable scie ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion in cash and ...

BioStat.AI is built on the foundation of EDETEK's flagship platforms, CONFORM™ and eClinical, and leverages advanced AI technologies including large language models (LLMs), machine learning, and ...